A human recurrent cutaneous melanoma (RPM) [24] lacking CD44 was resistant to iota toxin over a broad concentration range; however, these same cells following transfection with the CD44 gene importantly became susceptible to these same concentrations of iota toxin (Fig. 2A). This evidence concerns the gene CD44 and cutaneous melanoma.